• Bay 11-7821 in NF-κB Inflammation Workflows

  2026-09-16

  Bay 11-7821 (BAY 11-7082) gives researchers a practical way to test whether IKK–NF-κB activity links innate immune stimulation to cytokine output, cell survival, or tumor-cell growth. This workflow-focused guide covers monocyte inflammation assays, cancer models, controls, dosing logic, and troubleshooting.

• 25-Hydroxycholesterol Reprograms Tumor Macrophages

  2026-09-15

  The 2024 Immunity study identifies CH25H-derived 25-hydroxycholesterol as an immunometabolic checkpoint that links lysosomal sterol handling to AMPKα–STAT6 signaling and ARG1 production in tumor-associated macrophages. Its findings provide a mechanistic explanation for macrophage-mediated immune suppression and show why CH25H targeting can improve T-cell surveillance and anti-PD-1 responses.

• Autophagy and Cementoblast Mineralization Under Compression

  2026-09-15

  The reference study identifies autophagy as a functional mediator of cementoblast mineralization under compressive force and links this response to a periostin/β-catenin signaling axis. Its cell, transcriptomic, and mouse experiments provide a mechanistic framework for understanding cementum damage during orthodontic tooth movement and for designing pathway-focused regeneration studies.

• Sulfo-NHS-LC-Biotin: Practical Labeling Guide

  2026-09-14

  Sulfo-NHS-LC-Biotin provides covalent biotin labeling of primary amines on proteins, peptides, and accessible cell-surface proteins in aqueous workflows. It is suited to permanent extracellular tagging and subsequent biotin-avidin capture, but not to reversible labeling or intracellular targets.

• Protease Inhibitor Cocktail for OXPHOS Assays

  2026-09-14

  Discover how a Protease Inhibitor Cocktail and EDTA-Free Protease Inhibitor improve protein preservation and interpretation in dual-genome OXPHOS experiments. This guide connects protease control with LRPPRC–dasatinib assay design, sample integrity, and practical workflow decisions.

• SMAD3 Inhibition and ADAMTS-5 in Early Osteoarthritis

  2026-09-13

  Xiang et al. show that pharmacologic SMAD3 inhibition lowers ADAMTS-5 while increasing miRNA-140 in inflammatory chondrocytes and early osteoarthritis cartilage. The study links the TGF-β signaling pathway to a potentially actionable miRNA-mediated mechanism of cartilage protection, while also defining important limits for translation beyond the rat model.

• Norovirus Co-opts NINJ1 for Selective Secretion

  2026-09-12

  Song et al. show that murine norovirus repurposes the membrane-rupture protein NINJ1 to release the viral NS1 protein through a caspase-3-dependent unconventional pathway. The study connects viral immune evasion with regulated cell death and provides a mechanistic framework for examining selective protein export during enteric infection.

• In Vitro Drug Response Metrics in Cancer

  2026-09-11

  Hannah Schwartz’s dissertation shows why relative viability and fractional viability should not be treated as interchangeable measures of anticancer activity. By separating proliferative inhibition from cell killing and considering their different timing, the work provides a more informative framework for interpreting drug responses in vitro and designing follow-up experiments.

• Peroxynitrite, Ca2+ Flux, and Cardiac I/R Injury

  2026-09-11

  Liu et al. identify an ONOO−-driven endoplasmic reticulum–mitochondria calcium pathway that links hyperhomocysteinemia to cardiac microvascular endothelial necroptosis during ischemia–reperfusion. Their results position IP3R-dependent calcium transfer as a mechanistically supported intervention point and provide a framework for distinguishing upstream oxidative injury from downstream membrane-disruptive cell death.

• EGCG in 3D Bone Scaffold Assays

  2026-09-10

  (-)-Epigallocatechin gallate (EGCG) is more than a soluble green tea catechin: in 3D calcium phosphate scaffolds, its release profile changes how osteogenic, vascular, anti-tumor, and apoptosis assays should be designed. This article explains the study-to-workflow decisions that connect EGCG exposure kinetics with translational bone-regeneration research.

• Risedronate Sodium: An Assay-First Guide

  2026-09-10

  Risedronate Sodium is more than a conventional antiresorptive: its FPP synthase inhibitor activity connects mevalonate biology, osteoclast assays, and lung-targeted delivery. This guide translates the latest dendrimer study into practical decisions about controls, dosing, formulation, and interpretation.

• Etomoxir: From FAO Mechanism to Translation

  2026-09-09

  Etomoxir is more than a CPT-1 tool: it is a strategic perturbation for connecting fatty acid oxidation, lipid remodeling, and immune function. This thought-leadership guide examines how to use Etomoxir and R-(+)-Etomoxir responsibly across standardized whole-blood assays, cellular systems, and the experimental autoimmune encephalomyelitis model while managing DGAT-related confounding and translational limitations.

• AT-406 (SM-406): From IAP Biology to Translation

  2026-09-09

  AT-406 (SM-406) offers a mechanistically defined way to study IAP-dependent survival, apoptosis pathway activation in cancer cells, and chemotherapy sensitization. This thought-leadership perspective connects its preclinical oncology evidence with lessons from in vivo CRISPR screening while outlining a disciplined path from assay design to translational decision-making.

• Nanoparticle Uptake in Human Corneal Epithelium

  2026-09-08

  This 2024 study shows that nanoparticle size and surface chemistry jointly influence uptake by human corneal epithelial cells, with energy-dependent endocytosis, macropinocytosis, and caveolae-mediated entry emerging as the main mechanisms. Its in vitro design provides a practical framework for comparing ocular nanoparticle formulations while emphasizing the limits of translating cell uptake directly into clinical delivery.

• WY-14643: From PPARα Biology to Translation

  2026-09-08

  WY-14643, also known as Pirinixic Acid, is more than a standard PPARα agonist. Its value lies in connecting lipid metabolism regulation, endothelial inflammation, insulin sensitivity enhancement, and emerging tumor-microenvironment biology while providing a tractable benchmark for translational study design.

8569 records 1/572 page Next 12345 下5页 Last page